ALKATIはALK融合のないヒスティオサイト性腫瘍における核ALK発現を誘導する
Zofia Hélias-Rodzewicz1, Irena Antonia Ungureanu1, Paul Geraeds Kemps2
1EA4340-BECCOH, Department of Pathology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris. Université Paris-Saclay, Boulogne, France.
まとめ
No abstract available in PubMed .
関連する概念動画
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K


